The Journal of
Clinical Psychiatry

Volume 63 • 2002 • Supplement 9

Article

Article

Introduction: Cardiovascular and Metabolic Risks Associated With Schizophrenia and Antipsychotic Drug Treatment

J Clin Psychitary 2002;63(suppl 9):3-4

Herbert Y. Meltzer, MD

Article

Risk of Cardiovascular Disease and Sudden Death in Schizophrenia

J Clin Psychiatry 2002;63(suppl 9):5-11

Michael Davidson, MD

Article

Clinical Management of Cardiovascular Risks During Treatment With Psychotropic Drugs

J Clin Psychiatry 2002;63(suppl 9):12-17

Alexander Glassman, MD

Article

Mechanisms and Risks of Electrocardiographic QT Interval Prolongation When Using Antipsychotic Drugs

J Clin Psychiatry 2002;63(suppl 9):18-24

W. Victor R. Vieweg, MD

Article

Assessing Cardiovascular Risks Versus Clinical Benefits of Atypical Antipsychotic Drug Treatment

J Clin Psychiatry 2002;63(suppl 9):25-29

Herbert Y. Meltzer, MD ; Michael Davidson, MD ; Alexander H. Glassman, MD ; W. Victor R. Vieweg, MD